Evaluation of AI-Mouse Use in Patients With Hand and Wrist Conditions (NCT07707089) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Evaluation of AI-Mouse Use in Patients With Hand and Wrist Conditions
15 participantsStarted 2026-07
Plain-language summary
People with hand and wrist conditions, such as carpal tunnel syndrome or hand injuries, often experience pain and discomfort when using a computer mouse. This study will evaluate a new artificial intelligence (AI)-assisted computer input system ("AI-mouse") designed to reduce the amount of hand movement needed during computer tasks. Participants will complete short computer-based tasks using both a conventional mouse and the AI-assisted system while researchers measure task performance, muscle activity using surface electromyography (EMG), and participants' ratings of pain, physical strain, and usability. The study aims to determine whether the AI-assisted system can reduce physical effort and muscle load while maintaining effective computer interaction. Findings may help improve accessible computer technologies and support the development of ergonomic tools for people with hand and wrist impairments.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 18-65 years
* Diagnosis of a hand or wrist condition, including carpal tunnel syndrome or hand/wrist injury.
* Receiving care at the Hand Surgery Department of the National Scientific Center of Traumatology and Orthopedics.
* Medically stable and assessed by a study physician as able to safely perform light computer-based hand movements.
* Able to understand the study procedures and provide written informed consent.
* Normal or corrected-to-normal vision sufficient to complete computer-based tasks.
Exclusion Criteria:
* Severe pain or acute symptoms that may be aggravated by computer task performance.
* Postoperative restrictions limiting hand or wrist movement.
* Severe motor impairment preventing completion of the study tasks.
* Cognitive or neurological disorders that interfere with understanding study procedures or task performance.
* Uncorrected visual impairment that interferes with computer use.
* Any medical condition that, in the opinion of the study physician, would make participation unsafe.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
APDF90 surface electromyography (sEMG) amplitude
Timeframe: Baseline (during each intervention condition on Day 1)
2
Muscular rest time
Timeframe: Baseline (during each intervention condition on Day 1)